2025 Health in Review: Challenges and Triumphs
Dive into the 2025 Health in Review, reflecting on South Africa's healthcare struggles and clinical successes in HIV and TB treatment.
Health Funding Shortages Impacting HIV/AIDS Care
Examine the dangers of inadequate health funding in South Africa and the potential diversion of critical resources.
Ritshidze Report Highlights Decline in Services
The Ritshidze Report highlights a decline in South Africa clinic services due to PEPFAR cuts impacting healthcare delivery.
HIV Funding Boost Revealed by Health Minister Motsoaledi
South Africa receives a significant R2 billion HIV funding boost from the US CDC to sustain crucial health initiatives.
Health Funding Solution: Steps by National Treasury
Explore the health funding solution proposed by the National Treasury to address critical shortfalls in South Africa's healthcare system.
Global Fund Replenishment: Addressing Critical Needs
Learn why Global Fund replenishment is critical to combat AIDS, TB, and malaria amid severe health financing cuts.
UNAIDS Closure Causes Outrage Among Health Advocates
Activists warn that the UNAIDS closure will critically affect HIV/AIDS progress, calling for urgent global health action.
America First Health Policy Threatens Global Health Aid
The future of US health aid is uncertain. Find out how the America First health policy threatens HIV/Aids support in South Africa.
Gilead’s Lenacapavir to Reach High-Burden Nations ‘At Cost’
Gilead’s Lenacapavir is set to revolutionise HIV prevention efforts, aiming to protect two million people across affected nations.
PEPFAR Funding Secure for Vital HIV Programmes
The United States Congress has spared the President’s Emergency Plan for AIDS Relief (PEPFAR), a cornerstone of global HIV/AIDS prevention for nearly two decades, from a potential $400 million budget cut.. The proposed reduction was part of the Trump administration’s wider “rescissions package.” This package aimed at clawing back $9.4 billion in previously approved federal…...